| Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | Dec'13 | Dec'12 | Dec'11 | Dec'10 |
|---|---|---|---|---|---|---|---|---|---|
CASH FLOWS FROM OPERATING ACTIVITIES: | |||||||||
NET LOSS FROM CONTINUING OPERATIONS | |||||||||
-2,269 | - | - | - | - | - | - | - | - | - |
NET LOSS | |||||||||
- | -16,999 | -1,578 | -1,817 | - | - | - | - | - | - |
Net loss | |||||||||
- | - | - | - | -969 | -617 | -180 | 88 | 2,046 | 4,302 |
Adjustments to reconcile net loss to cash used in operating activities: | |||||||||
Depreciation and amortization | |||||||||
261 | 1,038 | 944 | 998 | 1,273 | 844 | 831 | 842 | 588 | 394 |
Inventories impairment reserve | |||||||||
184 | - | - | - | - | - | - | - | - | - |
Allowance for (reversal of allowance for) doubtful accounts | |||||||||
- | - | - | - | - | - | - | - | - | 6 |
Gain on disposal of property, plant and equipment | |||||||||
- | - | - | - | - | - | - | - | - | 0 |
Stock based compensation | |||||||||
- | - | 355 | 96 | 0 | - | - | - | - | - |
Gain on disposal of property | |||||||||
- | 14 | 37 | 0 | - | - | - | - | - | - |
Gain on disposal of plant and equipment | |||||||||
- | - | - | - | - | -20 | 28 | 0 | - | - |
Loss on closedown of a subsidiary | |||||||||
- | - | - | - | - | -18 | 0 | - | - | - |
Allowance for doubtful accounts | |||||||||
- | - | - | - | -442 | -325 | 5 | - | - | - |
(Recovery of) allowance for doubtful accounts | |||||||||
- | - | - | - | - | - | - | -28 | - | - |
Shares issued for services rendered | |||||||||
- | - | - | - | - | 190 | 128 | 0 | - | - |
Amortization of deferred compensation | |||||||||
- | - | - | - | - | 94 | 0 | - | - | - |
Allowance for doubtful accounts | |||||||||
20 | 14,736 | - | - | - | - | - | - | 0 | - |
Amortization of discount of convertible promissory notes | |||||||||
104 | - | - | - | - | - | - | - | - | - |
Change in derivative liabilities | |||||||||
437 | - | - | - | - | - | - | - | - | - |
Deferred tax expense | |||||||||
- | - | - | - | - | - | - | - | - | 1 |
Interest expenses, non-cash | |||||||||
- | - | - | - | - | - | 16 | 19 | 70 | 396 |
Write-back of contingent liability | |||||||||
- | - | - | - | - | - | 0 | - | - | - |
Settlement of interest payable in lieu of stock | |||||||||
- | - | - | - | - | 200 | 34 | 0 | - | - |
Change in operating assets and liabilities | |||||||||
Accounts receivable | |||||||||
-48 | - | - | - | - | - | - | - | - | - |
Advances to suppliers | |||||||||
47 | - | - | - | - | - | - | - | - | - |
Accounts and retention receivable | |||||||||
- | 846 | 4,814 | -473 | 70 | 3,717 | -2,021 | -3,844 | 2,673 | 2,040 |
Inventories | |||||||||
-106 | -1,055 | -2,746 | -2,074 | 1,795 | 2,994 | 1,383 | 620 | -271 | 158 |
Prepayments and other receivables | |||||||||
-93 | -720 | 316 | 909 | 769 | -238 | 29 | -494 | -393 | 495 |
Accounts payable, trade | |||||||||
-66 | -585 | 330 | -1,212 | -648 | 4,731 | -335 | -1,313 | -1,652 | 1,343 |
Advances from customers | |||||||||
-50 | - | - | - | - | - | - | - | - | - |
Taxes payable | |||||||||
-12 | 11 | - | - | - | -0 | 39 | -131 | -32 | -85 |
Other payables and accrued liabilities | |||||||||
-1 | 510 | 1,388 | 457 | 63 | 71 | -145 | -275 | 357 | -290 |
Net cash used in operating activities from continuing operations | |||||||||
-1,094 | - | - | - | -2,473 | -995 | 892 | 2,976 | - | - |
Net cash used in operating activities from discontinued operations | |||||||||
-970 | - | - | - | - | - | - | - | - | - |
Net cash used in operating activities | |||||||||
-2,064 | -343 | -908 | 159 | - | - | - | - | -610 | 3,359 |
CASH FLOWS FROM INVESTING ACTIVITIES: | |||||||||
Cash received from acquisition of the Pharmacy Group | |||||||||
116 | - | - | - | - | - | - | - | - | - |
Net cash provided by investing activities from continuing operations | |||||||||
116 | - | - | - | 1,588 | -341 | -921 | -3,250 | - | - |
Net cash provided by investing activities from discontinued operations | |||||||||
49 | - | - | - | - | - | - | - | - | - |
Issuance of share from placement | |||||||||
- | - | - | - | - | - | - | - | - | 900 |
Deposit payment on property purchase | |||||||||
- | - | - | - | - | - | - | 2,215 | - | - |
Deposit payment on property purchase | |||||||||
- | - | - | - | - | - | - | - | 0 | - |
Payments on construction in progress | |||||||||
- | - | - | 216 | 458 | 122 | 984 | 971 | 3,122 | 4,836 |
Net cash provided by investing activities | |||||||||
166 | - | - | -407 | - | - | - | - | -3,161 | -4,877 |
CASH FLOWS FROM FINANCING ACTIVITIES: | |||||||||
Issuance of common stock | |||||||||
- | 500 | - | - | - | - | - | - | - | - |
Net proceeds from issuance of convertible promissory notes | |||||||||
837 | - | - | - | - | - | - | - | - | - |
Amount financed from related parties | |||||||||
178 | - | - | - | - | - | - | - | - | - |
Purchase of property, plant and equipment | |||||||||
- | - | - | 191 | 204 | 218 | 96 | 63 | 38 | 42 |
Proceeds from disposal of property, plant and equipment | |||||||||
- | - | - | - | 2,251 | 0 | 158 | 0 | - | 1 |
Advance from non-controlling interest | |||||||||
- | - | - | 0 | - | - | - | - | - | - |
(Repayment on) proceeds from note payable, related party | |||||||||
- | - | - | - | - | - | - | 1,578 | - | - |
Loan to related party | |||||||||
- | - | - | - | - | - | - | - | 112 | 318 |
Amount due to related company | |||||||||
- | -769 | -16 | - | - | - | - | - | - | - |
Payments on finance lease | |||||||||
- | - | - | - | - | - | - | 34 | 508 | 607 |
Net cash provided by financing activities from continuing operations | |||||||||
1,016 | - | - | - | 48 | 1,626 | -2,093 | 1,013 | - | - |
Net cash provided by (used in) financing activities from discontinued operations | |||||||||
819 | - | - | - | - | - | - | - | - | - |
Decrease in restricted cash | |||||||||
- | -1,058 | - | 1,806 | 0 | - | -1,129 | 791 | -1,549 | - |
Proceeds of note payable from a related party | |||||||||
- | - | - | - | - | - | - | - | 1,500 | - |
Repayment to bank demand notes | |||||||||
- | - | - | - | - | - | 1,609 | - | - | - |
Proceeds from short-term bank borrowings | |||||||||
- | 6,047 | 6,955 | 6,021 | 6,433 | 6,180 | 6,372 | 5,403 | 5,631 | 1,475 |
Repayment on short-term bank borrowings | |||||||||
- | 6,047 | 5,919 | 7,872 | 6,385 | 4,554 | 5,727 | 6,724 | 0 | - |
Net cash provided by financing activities | |||||||||
1,836 | 211 | 1,052 | -45 | - | - | - | - | 5,186 | 2,086 |
EFFECT OF EXCHANGE RATE ON CASH | |||||||||
98 | 47 | 13 | -17 | -32 | -6 | 71 | 13 | 79 | 27 |
INCREASE IN CASH | |||||||||
36 | -84 | 157 | -309 | -869 | 283 | -2,050 | 753 | 1,493 | 596 |
SUPPLEMENTAL CASH FLOW INFORMATION: | |||||||||
Cash paid for tax | |||||||||
- | - | - | 0 | -38 | 65 | - | - | - | - |
Cash paid for income tax | |||||||||
- | 0 | 2 | - | - | - | 7 | 222 | 333 | 862 |
Cash paid for interest expense | |||||||||
- | 388 | 353 | 354 | - | - | - | - | - | - |
Cash paid for interest | |||||||||
- | - | - | - | 368 | 330 | 507 | 448 | 275 | 91 |
NON-CASH TRANSACTIONS OF INVESTING AND FINANCING ACTIVITIES | |||||||||
Issuance of common share for equity acquisition of the Pharmacy Group | |||||||||
3,090 | - | - | - | - | - | - | - | - | - |
Intangible assets recognized from equity acquisition of the Pharmacy Group | |||||||||
8,208 | - | - | - | - | - | - | - | - | - |
Outstanding payment for equity acquisition of the Pharmacy Group | |||||||||
5,655 | - | - | - | - | - | - | - | - | - |
Settlement of note payable to offset with accounts receivable | |||||||||
- | - | - | - | - | - | - | - | - | 544 |
Conversion of promissory notes | |||||||||
- | - | - | - | 1,718 | 0 | 960 | 0 | - | - |
Prepayment for construction in progress in lieu of accounts receivable | |||||||||
- | - | - | - | - | - | - | - | 7,830 | - |
Transfer from construction in progress to property, plant and equipment | |||||||||
- | - | - | - | - | - | - | - | 7,276 | 2,167 |
Transfer from construction in progress to land use right | |||||||||
- | - | - | - | - | - | - | - | - | 3,044 |